N

NEVRO Corp
D

NVRO

4.58000
USD
0.27
(6.14%)
Market Closed
Volume
18,636
EPS
-3
Div Yield
-
P/E
-2
Market Cap
171,620,029
Related Instruments
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    B
    BAX
    0.260
    (0.82%)
    31.970 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    538.87 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.310 USD
    SYK
    SYK
    6.90
    (1.80%)
    387.88 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    521.81 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: NEVRO Corp

Sector: Healthcare
Industry: Medical Devices
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.